+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Parenteral Nutrition Market by Nutrient Type, Dosage Form, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968576
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Parenteral Nutrition Market grew from USD 7.67 billion in 2023 to USD 8.33 billion in 2024. It is expected to continue growing at a CAGR of 8.66%, reaching USD 13.73 billion by 2030.

Parenteral Nutrition (PN) is defined as the medical administration of nutritional support intravenously, bypassing the digestive system, to patients who cannot consume or absorb nutrients via the gastrointestinal tract. The necessity of PN arises in cases of severe digestive disorders, trauma, surgeries, or chronic illnesses. It is predominantly applied in hospital settings, catering to a diverse range of patients from neonates to adults, who require life-sustaining nutrition without oral or enteral intake options. Major end-users include hospitals, clinics, and homecare settings, where PN is adapted for outpatient chronic care needs. Market growth is significantly influenced by the rising prevalence of chronic diseases, advancements in healthcare infrastructure, and increasing adoption of homecare nutrition. The growing aging population further necessitates tailored nutritional solutions like PN. Potential opportunities include developing formulations that provide tailored lipids, amino acids, and micronutrients, meeting specific patient requirements, and enhancing delivery systems for safety and efficacy. Emphasis on home-based PN can open new avenues for growth, especially with technological advancements in portable infusion systems. However, the market is challenged by high costs, complexities in admixture preparation, risk of infections, and stringent regulatory approvals affecting product reach and development pace. Moreover, awareness and expertise in administering PN remain uneven across regions, posing barriers in emerging markets. Innovation should focus on designing safer, easy-to-use delivery systems, enhancing the stability of emulsions, expanding patient education, and tele-health consultations to support homecare PN. The PN market is characterized by its high entry barriers due to stringent regulation and the need for specialized expertise. Yet, the growing comfort with personalized medical solutions and telemedicine offers fertile ground for research and development, particularly in optimizing patient nutrition through innovative delivery technologies and formulations.

Understanding Market Dynamics in the Parenteral Nutrition Market

The Parenteral Nutrition Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
    • Increasing rate of geriatric population and malnourished individuals
    • High natality and premature births around the globe
  • Market Restraints
    • Strict government rules regarding the approval of parenteral nutrition
  • Market Opportunities
    • Innovative parenteral and enteral nutrition therapy
    • Technological developments in parenteral nutrition
  • Market Challenges
    • Associated complexities with parenteral nutrition

Exploring Porter’s Five Forces for the Parenteral Nutrition Market

Porter’s Five Forces framework further strengthens the insights of the Parenteral Nutrition Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Parenteral Nutrition Market

External macro-environmental factors deeply influence the performance of the Parenteral Nutrition Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Parenteral Nutrition Market

The Parenteral Nutrition Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Parenteral Nutrition Market

The Parenteral Nutrition Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Parenteral Nutrition Market

The Parenteral Nutrition Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Parenteral Nutrition Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ACULIFE HEALTHCARE PRIVATE LIMITED, ALBERT DAVID LIMITED by Kothari Group, Amanta Healthcare Ltd., AMINO GmbH, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Evonik Industries AG, Fresenius Kabi AG, Grifols S.A., Hamilton Bonaduz AG, ICU Medical, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Well Pharma Medical Solutions LLC.

Market Segmentation & Coverage

This research report categorizes the Parenteral Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Nutrient Type
    • Amino Acids
    • Carbohydrates
    • Electrolytes
    • Lipids
    • Multivitamin Formulations & Trace Elements
  • Dosage Form
    • Ampules
    • Bags
    • Bottles
    • Vials
  • End-User
    • Clinics
    • Hospitals
    • Long-Term Care Providers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
5.1.1.2. Increasing rate of geriatric population and malnourished individuals
5.1.1.3. High natality and premature births around the globe
5.1.2. Restraints
5.1.2.1. Strict government rules regarding the approval of parenteral nutrition
5.1.3. Opportunities
5.1.3.1. Innovative parenteral and enteral nutrition therapy
5.1.3.2. Technological developments in parenteral nutrition
5.1.4. Challenges
5.1.4.1. Associated complexities with parenteral nutrition
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Parenteral Nutrition Market, by Nutrient Type
6.1. Introduction
6.2. Amino Acids
6.3. Carbohydrates
6.4. Electrolytes
6.5. Lipids
6.6. Multivitamin Formulations & Trace Elements
7. Parenteral Nutrition Market, by Dosage Form
7.1. Introduction
7.2. Ampules
7.3. Bags
7.4. Bottles
7.5. Vials
8. Parenteral Nutrition Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
8.4. Long-Term Care Providers
9. Americas Parenteral Nutrition Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Parenteral Nutrition Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Parenteral Nutrition Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PARENTERAL NUTRITION MARKET RESEARCH PROCESS
FIGURE 2. PARENTERAL NUTRITION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PARENTERAL NUTRITION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PARENTERAL NUTRITION MARKET DYNAMICS
TABLE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LIPIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY MULTIVITAMIN FORMULATIONS & TRACE ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMPULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LONG-TERM CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 34. CANADA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. CHINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 51. CHINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. INDIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 54. INDIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 60. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 78. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 88. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 94. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 97. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 100. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. ITALY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. ITALY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 115. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. POLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 118. POLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. QATAR PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. QATAR PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 133. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 142. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Parenteral Nutrition Market, which are profiled in this report, include:
  • AbbVie Inc.
  • ACULIFE HEALTHCARE PRIVATE LIMITED
  • ALBERT DAVID LIMITED by Kothari Group
  • Amanta Healthcare Ltd.
  • AMINO GmbH
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Claris Lifesciences Limited
  • Evonik Industries AG
  • Fresenius Kabi AG
  • Grifols S.A.
  • Hamilton Bonaduz AG
  • ICU Medical, Inc.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Well Pharma Medical Solutions LLC

Methodology

Loading
LOADING...

Table Information